Development Research Project (DRP)
发展研究项目(DRP)
基本信息
- 批准号:10705145
- 负责人:
- 金额:$ 14.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-18 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Summary of Developmental Projects Program (DRP)
To ensure a continual renewal of high-quality scientific endeavors in the DF/HCC Kidney Cancer SPORE
and to fund efforts that will complement or enhance the overall quality of the DF/HCC Kidney Cancer
SPORE. In general, the DRP has funded established investigators. Based on our review, we will be mindful
of including more junior investigators. This Program will rely on the infrastructure created by the
Administrative, Evaluation, and Planning Core (Admin Core) to:
1. Solicit applications and/or identify novel kidney cancer research projects.
2. Evaluate these projects for funding.
3. Fund innovative developmental projects.
4. Re-evaluate projects for possible transition into full project status.
5. Evaluate the success of the program.
发展计划概要(DRP)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David McDermott其他文献
David McDermott的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David McDermott', 18)}}的其他基金
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
肾损伤分子 1 (KIM-1) 作为肾细胞癌生物标志物的临床特征
- 批准号:
10365631 - 财政年份:2021
- 资助金额:
$ 14.34万 - 项目类别:
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
肾损伤分子 1 (KIM-1) 作为肾细胞癌生物标志物的临床特征
- 批准号:
10541150 - 财政年份:2021
- 资助金额:
$ 14.34万 - 项目类别:
Project 3: HHLA2 as a THerapeutic Target in RCC
项目 3:HHLA2 作为 RCC 的治疗靶点
- 批准号:
10206027 - 财政年份:2003
- 资助金额:
$ 14.34万 - 项目类别:
DF/HCC Kidney Cancer SPORE Administrative Core
DF/HCC 肾癌 SPORE 管理核心
- 批准号:
10206019 - 财政年份:2003
- 资助金额:
$ 14.34万 - 项目类别:
DF/HCC Kidney Cancer SPORE Administrative Core
DF/HCC 肾癌 SPORE 管理核心
- 批准号:
10705111 - 财政年份:2003
- 资助金额:
$ 14.34万 - 项目类别:
Project 3: HHLA2 as a THerapeutic Target in RCC
项目 3:HHLA2 作为 RCC 的治疗靶点
- 批准号:
10705141 - 财政年份:2003
- 资助金额:
$ 14.34万 - 项目类别:
相似国自然基金
Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating the role of complement component 5a in ANCA-associated vasculitis
研究补体成分 5a 在 ANCA 相关血管炎中的作用
- 批准号:
MR/Y000854/1 - 财政年份:2024
- 资助金额:
$ 14.34万 - 项目类别:
Fellowship
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 14.34万 - 项目类别:
NSF Convergence Accelerator, Track M: TANDEM: Tensegrity-based Assistive aND rehabilitation Exosuits to complement human bioMechanics
NSF 融合加速器,轨道 M:TANDEM:基于张拉整体的辅助和康复外装,以补充人体生物力学
- 批准号:
2344385 - 财政年份:2024
- 资助金额:
$ 14.34万 - 项目类别:
Standard Grant
Development of a novel oral vaccine for fish: Synergy of chitosan nano particle and complement-mediated opsonization
新型鱼类口服疫苗的开发:壳聚糖纳米颗粒与补体介导的调理作用的协同作用
- 批准号:
24K17960 - 财政年份:2024
- 资助金额:
$ 14.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Crosstalk between purinergic signaling and the complement system in sepsis-induced immunosuppression.
脓毒症引起的免疫抑制中嘌呤能信号传导与补体系统之间的串扰。
- 批准号:
23H03013 - 财政年份:2023
- 资助金额:
$ 14.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Complement Protein C1q Regulation of Macrophage Metabolic Pathways
补体蛋白 C1q 对巨噬细胞代谢途径的调节
- 批准号:
10629550 - 财政年份:2023
- 资助金额:
$ 14.34万 - 项目类别:
Defining the impact of complement inhibition by tick saliva in tick-borne virus evolution and adaptive immune responses in murine models of infection
定义蜱唾液抑制补体对蜱传病毒进化和小鼠感染模型适应性免疫反应的影响
- 批准号:
10535945 - 财政年份:2023
- 资助金额:
$ 14.34万 - 项目类别:
Complement Resistance Acquired During Acute to Persistent Rubulavirus Infection
急性至持续性风疹病毒感染期间获得的补体耐药性
- 批准号:
10645486 - 财政年份:2023
- 资助金额:
$ 14.34万 - 项目类别:
Inhibition of Complement Pathways with VCP As A Treatment For Alzheimer's Disease
VCP 抑制补体途径治疗阿尔茨海默病
- 批准号:
10602757 - 财政年份:2023
- 资助金额:
$ 14.34万 - 项目类别: